Tilray Brands (TLRY) Other Non-Current Assets (2017 - 2026)
Tilray Brands (TLRY) posted Other Non-Current Assets of $11.1 million for Q1 2026, little changed on a QoQ basis from $11.1 million in Q4 2025.
Tilray Brands (TLRY) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Tilray Brands' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $11.1 million for Q1 2026.
- Quarterly Other Non-Current Assets changed N/A year-over-year to $11.1 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $11.1 million (changed N/A YoY) and the FY2025 annual result came in at $11.1 million, up 105.45% from the prior year.
- Other Non-Current Assets was $11.1 million for Q1 2026 at Tilray Brands, roughly flat from $11.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $11.7 million in Q3 2025 and bottomed at $222000.0 in Q2 2023.
- A 5-year average of $6.2 million and a median of $5.4 million in 2024 frame the typical range for Other Non-Current Assets.
- Peak annual rise in Other Non-Current Assets reached 2825.0% in 2022, while the deepest fall reached 96.21% in 2022.
- Tilray Brands' Other Non-Current Assets stood at $4.8 million in 2022, then jumped by 96.08% to $9.4 million in 2023, then tumbled by 45.81% to $5.1 million in 2024, then surged by 117.25% to $11.1 million in 2025, then climbed by 0.01% to $11.1 million in 2026.
- Business Quant data shows TLRY's Other Non-Current Assets at $11.1 million in Q1 2026, $11.1 million in Q4 2025, and $11.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 49.22 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.79 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 351.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 491.06 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 233.20 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.11 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 73.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 295.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 11.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 11.07 Mn |
| Nov 30, 2025 | 11.07 Mn |
| Aug 31, 2025 | 11.66 Mn |
| May 31, 2025 | 11.08 Mn |
| Nov 30, 2024 | 5.10 Mn |
| Aug 31, 2024 | 5.34 Mn |
| May 31, 2024 | 5.40 Mn |
| Feb 29, 2024 | 5.61 Mn |
| Nov 30, 2023 | 9.41 Mn |
| Aug 31, 2023 | 8.65 Mn |
| May 31, 2023 | 222,000.00 |
| Feb 28, 2023 | 4.99 Mn |
| Nov 30, 2022 | 4.80 Mn |
| Aug 31, 2022 | 4.75 Mn |
| May 31, 2022 | 314,000.00 |
| Feb 28, 2022 | 314,000.00 |
| Nov 30, 2021 | 164,000.00 |
| Aug 31, 2021 | 198,000.00 |
| May 31, 2021 | 8.29 Mn |
| Mar 31, 2020 | 2.14 Mn |